15(top 1%)
papers
526(top 1%)
citations
8(top 1%)
h-index
14(top 1%)
g-index
16
all documents
541
doc citations
286
citing journals

Top Articles

#TitleJournalYearCitations
1Malignant “Triton” tumors. Natural history and immunohistochemistry of nine new cases with literature reviewCancer1985202
2Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsJournal of Neuro-Oncology1992109
3Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast CancerJournal of Clinical Oncology201283
4Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)Breast Cancer Research and Treatment201159
5Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myelomaLeukemia201034
6Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.Blood200522
7Outcome with Lenalidomide Plus Dexamethasone Followed by Early Autologous Stem Cell Transplantation In the ECOG E4A03 Randomized Clinical TrialBlood201016
8In Adults with Standard-Risk Acute Lymphoblastic Leukemia (ALL) the Greatest Benefit Is Achieved from an Allogeneic Transplant in First Complete Remission (CR) and an Autologous Transplant Is Less Effective Than Conventional Consolidation/Maintenance Chemotherapy: Final Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).Blood20068
9Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.Blood20062
10Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6Blood20112
11Does Concomitant Methotrexate (MTX) and GM-CSF Administration after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Predispose to Thrombotic Microangiopathy (TMA)?.Blood20041
12Frequent PML-RAR α Mutations in Relapse Patients on Acute Promyelocytic Leukemia (APL) Intergroup Phase III Trial C9710.Blood20061
13Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL)Blood20121
14Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG StudyBlood20111
15Editorial to the IJPO supplement on childhood obesityPediatric Obesity20080
16Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903.Blood20070